Consensus Pulmonx Corporation

Equities

LUNG

US7458481014

Real-time Estimate Cboe BZX Other stock markets 08:34:22 30/04/2024 pm IST			5-day change	1st Jan Change
7.535 ^USD	+0.47%		-0.40%	-41.41%

02/04	Pulmonx Appoints Mehul Joshi as Chief Financial Officer	MT
02/04	Pulmonx Corporation Announces Chief Financial Officer Changes, Effective April 3, 2024	CI

Evolution of the average Target Price on Pulmonx Corporation

Price target over the last 5 years

History of analyst recommendation changes

c894a72daa91f27ae110774ed4335.HHG6t5gPvAhlb2V4DQA3nHBvUSvpFQ-ZqmOtPTVSqQ8.ZR7-3tlF9HgxBCsAIEtd2h03aE2RVmDTnTLDVhg5mT9OXPiP2jrkZkhdUQ~356ccfa48c4cdaf1c891d02528b126d8

Analyst Recommendations on Pulmonx Corporation

Wells Fargo Downgrades Pulmonx to Equalweight From Overweight, Cuts Price Target to $14 From $16	23/02	MT
Canaccord Genuity Adjusts Pulmonx's Price Target to $16 From $12, Keeps Buy Rating	22/02	MT
Stifel Adjusts Pulmonx's Price Target to $17 From $15, Keeps Buy Rating	22/02	MT
Wells Fargo Adjusts Pulmonx's Price Target to $16 From $15, Keeps Overweight Rating	22/02	MT
Citigroup Adjusts Pulmonx's Price Target to $17 From $16, Keeps Buy Rating	22/02	MT
Craig-Hallum Adjusts Pulmonx's Price Target to $20 From $18, Keeps Buy Rating	22/02	MT
Craig-Hallum Initiates Pulmonx at Buy With $18 Price Target	05/23/05	MT
Citigroup Raises Price Target on Pulmonx to $16 From $14, Maintains Buy Rating	11/23/11	MT
Piper Sandler Adjusts Pulmonx's Price Target top $15 From $13, Keeps Overweight Rating	03/23/03	MT
Morgan Stanley Adjusts Pulmonx's Price Target to $14 From $11, Keeps Equalweight Rating	03/23/03	MT
Citigroup Adjusts Pulmonx Price Target to $13 From $12, Maintains Buy Rating	03/23/03	MT
Wells Fargo Upgrades Pulmonx to Overweight From Equalweight, Adjusts Price Target to $15 From $10	27/23/27	MT
Morgan Stanley Adjusts Price Target on Pulmonx to $11 From $9.50, Keeps Equalweight Rating	23/23/23	MT
Canaccord Genuity Adjusts Price Target on Pulmonx to $20 From $18, Maintains Buy Rating	23/23/23	MT
Morgan Stanley Adjusts Price Target on Pulmonx to $9.50 From $14, Maintains Equalweight Rating	06/23/06	MT
BofA Securities Downgrades Pulmonx to Underperform From Neutral With $8 Price Target	03/23/03	MT
Wells Fargo Cuts Price Target on Pulmonx to $6 From $13.50, Maintains Equalweight Rating	12/22/12	MT
Citigroup Upgrades Pulmonx to Buy From Neutral, Adjusts Price Target to $10 From $14	12/22/12	MT
Morgan Stanley Adjusts Price Target on Pulmonx to $14 From $19, Maintains Equal-Weight Rating	07/22/07	MT
Piper Sandler Adjusts Price Target on Pulmonx to $13 From $25, Maintains Overweight Rating	04/22/04	MT
Morgan Stanley Adjusts Pulmonx's Price Target to $19 from $21, Reiterates Equalweight Rating	11/22/11	MT
Morgan Stanley Raises Pulmonx's Price Target to $21 From $19, Maintains Equalweight Rating	04/22/04	MT
Piper Sandler Adjusts Price Target on Pulmonx to $25 From $37, Reiterates Overweight Rating	03/22/03	MT
Stifel Nicolaus Adjusts Price Target on Pulmonx to $20 From $32, Maintains Buy Rating	18/22/18	MT
Morgan Stanley Adjusts Price Target on Pulmonx to $19 From $30, Keeps Equalweight Rating	15/22/15	MT